1.67 MONALEESA-7 and the Cost of Cancer Drugs with Dr. Stacie Dusetzina
This week we begin the episode by discussing MONA…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
June 27, 20192h 20mExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week we begin the episode by discussing MONALEESA-7 and why ribociclib has been shown to increase overall survival while palbociclib has not. We finish the episode with an in-depth interview with Dr. Stacie Dusetzina of Vanderbilt University on her work in pharmacoeconomics, specifically we discuss her work on the market value of cancer drugs.
MONALEESA-7: doi.org/10.1056/NEJMoa1903765
Free drug samples are a marketing tool: doi.org/10.2105/AJPH.2007.114249
Back us on Patreon! www.patreon.com/plenarysession
Topics
medicineoncologyhealthpolicy